To investigate ACE-I, ARB and type 5 PDE-I drugs in the context of ARDS and microvascular dysfunction in Covid-19 patients.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. Arthur WallaceResearch Location
United States of AmericaLead Research Institution
University of California-San Francisco, San Francisco VA Medical CenterResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified